Impact of Pea, Lentil and Oat Flour Particle Size on Glycemic Response in Healthy Adults

NCT05291351 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-07-05

No results posted yet for this study

Summary

The study looks at the comparative effects of food products made with pea, lentil, and oat flour of various particle sizes on postprandial glycemic response, appetite and food intake, and amino acid release in healthy adults.

Conditions

  • Malnutrition; Diabetes
  • Malnutrition; Protein
  • Obesity

Interventions

OTHER

Crackers made with whole, coarse, or fine pea and/or wheat flour

Participants will consume 1 of the 4 treatments at each of 4 study sessions in random orders such that by the end of the study, they will have consumed all 4 treatments. They will be given 10 minutes to consume the entire treatment with a glass of water.

OTHER

Crackers made with whole, coarse, or fine lentil and/or wheat flour

Participants will consume 1 of the 4 treatments at each of 4 study sessions in random orders such that by the end of the study, they will have consumed all 4 treatments. They will be given 10 minutes to consume the entire treatment with a glass of water.

OTHER

Porridge made with oat flour

Participants will consume 1 of the 4 treatments at each of 4 study sessions in random orders such that by the end of the study, they will have consumed all 4 treatments. They will be given 10 minutes to consume the entire treatment with a glass of water.

Sponsors & Collaborators

  • University of Saskatchewan

    collaborator OTHER
  • Saskatchewan Food Industry Development Center

    collaborator UNKNOWN
  • University of Toronto

    lead OTHER

Principal Investigators

  • G. Harvey Anderson, PhD · University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05291351 on ClinicalTrials.gov